Resultados de la búsqueda 971-980 of 2814 for High-Intensity Interval Training

  1. Programa de tumores cerebrales - Ensayos clínicos

    Scottsdale/Phoenix, Ariz., Rochester, Minn. The purpose of this study is to combine MRI images with histologic and genetic analysis of cancer (from blood and ...

  2. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to determine the incidence of anogenital infection with high-risk HPV serotypes and HPV-associated anogenital lesions in female ...

  3. Oncología (médica) - Ensayos clínicos

    Jacksonville, Fla. The purpose of this study is to compare the effect of adding nivolumab to the usual chemotherapy (cisplatin or carboplatin with gemcitabine) ...

  4. Hematología - Ensayos clínicos

    The primary objectives are to determine the maximum tolerated dose (MTD) or highest protocol-defined dose (HPDD); in the absence of exceeding the MTD of MEDI- ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Using radiation techniques, such as intensity modulated radiotherapy to ...

  6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue.

  7. Agentes de acción central - Mayo Clinic

    Types of blood pressure medications. American Heart Association. https://www.heart.org/en/health-topics/high-blood-pressure/changes-you-can- ...

  8. Oncología (médica) - Ensayos clínicos

    Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage ...

  9. Neurocirugía - Ensayos clínicos

    ... high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression; (2) Cohort 2 focuses on primary or secondary ...

  10. Programa de tumores cerebrales - Ensayos clínicos

    ... high (80-90%) frequency of MUC1 expression and variably high (unreported to 50%) HER2/neu (“HER2”) expression; (2) Cohort 2 focuses on primary or secondary ...